AME

Ametek
D

AME

Arincen87/100B

Ametek executives and insider trading

David A. Zapico sold 116,390 shares for 23.01M USD in 4 sales over the last twelve months, the last on 12 December 2025, and bought none on the open market.

Over the last twelve months Ametek's insiders sold 146,926 shares for 29.55M USD in 9 sales on the open market, and bought 4,000 shares in 1 purchases.

Insiders over the last twelve months

Insider sales
9
Shares sold
146,926
Value sold
29.55M USD
Insider purchases
1

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
1.02M USD
3 months
0
1.02M USD
6 months
1.68M USD
1.02M USD
1 year
29.55M USD
1.02M USD
2 years
36.66M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
David A. Zapico CEOChairman of the Board & Chief Executive Officer61116,39023.01M USD—12 Dec 2025343,595
Thomas C Marecic PRES. - ELECTRONIC INSTRUMENTS—14,3102.89M USD—15 Dec 202545,053
David F. Hermance President of Electromechanical Group576,6081.68M USD—7 Aug 202649,117
Thomas M Montgomery SR. VP. - COMPTROLLER—6,3881.31M USD—22 Dec 202522,097
Nick L Stanage Director———4,000—4,760
Emanuela Speranza CHIEF COMMERCIAL OFFICER—2,700540.00K USD—12 Nov 202530,671
Thomas A Amato Director—530114.89K USD—24 Mar 20267,000

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
11 Aug 2026Nick L StanagePurchase4,000255.851.02M USD4,760Form 4
7 Aug 2026David F. HermanceSale6,608254.001.68M USD42,509Form 4
24 Mar 2026Thomas A AmatoSale530216.78114.89K USD4,480Form 4
22 Dec 2025Thomas M MontgomerySale6,388205.051.31M USD22,116Form 4
15 Dec 2025Thomas C MarecicSale14,310202.112.89M USD42,589Form 4
12 Dec 2025David A. ZapicoSale28,390201.765.73M USD—Form 4
25 Nov 2025David A. ZapicoSale7,432194.891.45M USD429,523Form 4
25 Nov 2025David A. ZapicoSale25,815195.825.06M USD403,708Form 4
25 Nov 2025David A. ZapicoSale54,753196.8610.78M USD348,955Form 4
12 Nov 2025Emanuela SperanzaSale2,700200.00540.00K USD28,293Form 4
31 Oct 2025Ronald J. OscherSale26,290200.055.26M USD40,226Form 4
11 Sept 2025John Wesley Hardin Jr.Sale7,867188.031.48M USD65,235Form 4
27 Mar 2025Thomas A AmatoSale710176.64125.41K USD10,560Form 4
3 Mar 2025Steven W KohlhagenSale1,320189.42250.03K USD22,029Form 4

Common questions about Ametek's executives and insiders

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.